Re: India's IP policies and US lawmakers.

There are also the laws and rules governing the use of genetically modified foodstuffs (some of which do not have hard seeds, so can be clubbed under software). See this report: http://www.huffingtonpost.com/2013/06/06/stephen-colbert-monsanto-gmo-seeds-wheat_n_3399249.html  
 
Vickram
http://communicall.wordpress.com
http://vvcrishna.wordpress.com



>________________________________
> From: ashijit pramanik <[email protected]>
>To: Banibrata Dutta <[email protected]> 
>Cc: "[email protected]" <[email protected]> 
>Sent: Sunday, 30 June 2013, 22:49
>Subject: Re: [india-gii] India's IP policies and US lawmakers.
> 
>
>
>Great, thanks. I will read up on this. I thought the IP policies mentioned in the article dealt with software and/or telecom patents as well - in case list members are curious why drug IP is being discussed. Though, I see TRIPS covers those as well, I guess the software lobby is much less powerful and we produce very little IP in other areas to be of any threat to US businesses.
>
>
>
>
>On Sun, Jun 30, 2013 at 10:34 PM, Banibrata Dutta <[email protected]> wrote:
>
>The following 3 articles should answer your query.
>>
>>http://en.wikipedia.org/wiki/TRIPS_Agreement
>>http://www.rsc.org/chemistryworld/News/2012/March/india-generics-natco-nexavar-compulsory-licence.asp
>>http://articles.economictimes.indiatimes.com/2013-06-10/news/39873056_1_patent-challenge-patent-infringement-cancer-drug-glivec
>>
>>India is a signatory to TRIPS, and in short, it means that India has agreed to accept some internationally accepted code-of-conduct regarding Intellectual Property (patents in this case... and most cases). International (read US based) pharma co. claims to have invested truckloads of time and money in developing cancer drugs, for which it expects to earn a healthy profit. They sold the drug in India, at costs which as per Indian govt. very few Indians could afford to buy it. This being a life-saving drug, India (SC in this case) went ahead and permitted Indian pharma companies to sell the drug at much lower price points, while paying a royalty to the co. which holds the patent. This way as per the US company, they earn much less, than what they could have, had Indian public been forced to buy the drugs at full international cost. This, as per the redneck congressman, is against the spirit of TRIPS (and (sic.) perhaps the concepts of capitalism).
>>
>>
>>
>>
>>On Sun, Jun 30, 2013 at 10:17 PM, ashijit pramanik <[email protected]> wrote:
>>
>>Can someone shed light on which IP policies they are talking about here:
>>>
>>>http://www.livemint.com/Politics/7OHPpGiNbNqk5r0UI3USDN/India-not-willing-to-play-by-the-rules-US-lawmakers.html
>>>
>>>“Like all of you, my blood boils when I hear that India is revoking and 
denying patents and granting compulsory licences for cancer treatments 
or adopting local content requirements,” he said. “As a nation, we 
should handle India like my dad did when I was growing up and I made his
 blood boil: He put his arm around me and or pulled me where he would 
go, to make sure his fingers were resting firmly on my shoulder just to 
inflict some pain if I diverted from the course we would go down. That’s
 what we should do with their government,” Olson said. (Congressman from Texas)
>>>
>>>-- 
>>>Regards
>>>Ashijit
>>>_______________________________________________
>>>India-gii mailing list
>>>[email protected]
>>>http://frodo.hserus.net/mailman/listinfo/india-gii
>>>
>>>
>>
>>
>>-- 
>>regards,
>>Banibrata
>>http://www.linkedin.com/in/bdutta
>>http://twitter.com/edgeliving 
>
>
>-- 
>Regards
>Ashijit
>_______________________________________________
>India-gii mailing list
>[email protected]
>http://frodo.hserus.net/mailman/listinfo/india-gii
>
>
>

_______________________________________________
India-gii mailing list
[email protected]
http://frodo.hserus.net/mailman/listinfo/india-gii